Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 2000

View Archived Issues

FDA approves novel assay for the diagnosis and management of alcohol abuse

Collateral Therapeutics boosts cardiovascular gene therapy portfolio with new patent

P&U will market Novo Nordisk's HRT products in U.S.

Isis and AstraZeneca establish antisense target validation program

Oxford BioMedica acquires novel antibody technology

Preparation, use and pharmaceutical compositions of new Galderma compounds

Kinase-inhibitory antiproliferative indolones in development at Boehringer Ingelheim

New Merck carbapenems with activity against methicillin-resistant staphylococci

New antioxidants from ADIR particularly useful for treating oxidative stress in the CNS

Porphyrin-based agents for PDT and MRI designed at Schering AG

Vertex patents heterocyclic p38 MAP kinase inhibitors and their use

Chinese-Thai collaboration will study traditional herbal remedies for AIDS and cancer

Previously unstudied tropical plant yields novel anti-HIV peptides

Skandigen announces name change

JAK3 identified as a new target for the treatment of ALS

Successful oral delivery of calcitonin reported by Novartis

Naltriben: potential new pharmacotherapeutic for reducing alcohol intake

Nippon Kayaku devotes significant resources to the fight against cancer

New anti-HIV compounds available for licensing from NIH

Matrix completes patient enrollment in pivotal head and neck cancer trials

Details behind formation of global leader in pharmaceuticals --Glaxo SmithKline-- released

European Commission approves new indication for AstraZeneca antiasthmatic

UCB acquires Fujirebio, thereby expanding UCB Japan

Apollo's neuroprotective vitamin D compounds covered by U.S. patent

Isolation of unnamed tick-borne bacterium causing HGE patented by Aquila

CpG ImmunoPharmaceuticals changes name

Four-year results from Early Postmenopausal Intervention Cohort Study presented

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...